Literature DB >> 9697058

Prosthesis-induced hemolysis: mechanisms and quantification of shear stress.

J T Ellis1, T M Wick, A P Yoganathan.   

Abstract

Over the past four decades, nearly three million prosthetic heart valves have been implanted worldwide. Despite improvements in valve designs and clinical management, the ideal mechanical heart valve has yet to be realized; hemolytic and thromboembolic complications remain the major obstacles. Towards this goal, a number of clinical and basic engineering studies have improved our understanding of how red blood cells can be damaged by the turbulent flow fields associated with current prosthetic mechanical heart valve designs. However, continued advances in understanding the hemolytic complications associated with different valve designs, and progress in making improvements to existing designs, will depend on the development of more sophisticated in vitro quantitative engineering techniques such as those described in this paper.

Entities:  

Mesh:

Year:  1998        PMID: 9697058

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  7 in total

1.  Hemolysis after mitral valve replacement with mechanical valve prostheses.

Authors:  M Ninomiya; K Yagyu; Y Kaneko; Y Kotsuka; S Takamoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-04

2.  Sarpogrelate reduces mechanical hemolysis in patients with heart valve prostheses.

Authors:  A Usui; Y Takagi; Y Ohara; O Kawaguchi; T Watanabe; Y Ueda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-12

3.  Hereditary spherocytosis and elliptocytosis associated with prosthetic heart valve replacement: rheological study of erythrocyte modifications.

Authors:  Patrizia Caprari; Anna Tarzia; Giorgio Mojoli; Paolo Cianciulli; Emilio Mannella; Maria Cristina Martorana
Journal:  Int J Hematol       Date:  2009-03-24       Impact factor: 2.490

4.  A curious case of persistently relapsing hyperkalemia in an ESRD patient on maintenance hemodialysis following bioprosthetic aortic valve replacement - a potential case for the use of the new agent, patiromer, for hyperkalemia management.

Authors:  Macaulay Amechi Chukwukadibia Onuigbo; Nneoma Agbasi; Fidelis Oguejiofor; Charles Odenigbo
Journal:  J Renal Inj Prev       Date:  2016-09-24

Review 5.  Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

Authors:  Konstantinos N Aronis; Elaine M Hylek
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501

6.  Bail-out use of the Amplatzer Septal Occluder for treatment of acute iatrogenic leaflet perforation during the MitraClip procedure in a patient with functional mitral regurgitation.

Authors:  Adrian Kłapyta; Jerzy Pręgowski; Zbigniew Chmielak; Piotr Szymański; Adam Witkowski; Marcin Demkow
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-09-21       Impact factor: 1.426

7.  Successful transcatheter aortic valve implantation in a patient after an apico-aortic conduit for severe aortic stenosis complicated by haemolytic anaemia: a case report.

Authors:  Kitae Kim; Natsuhiko Ehara; Tadaaki Koyama; Yutaka Furukawa
Journal:  Eur Heart J Case Rep       Date:  2020-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.